Entera Bio Ltd. Ordinary Shares (ENTX) is a publicly traded Healthcare sector company. As of September 17, 2026, ENTX trades at $2.93 with a market cap of $495.19M and a P/E ratio of 12.00. ENTX moved +3.32% today. Year to date, ENTX is +52.58%; over the trailing twelve months it is +62.64%. Its 52-week range spans $0.91 to $4.20. Analyst consensus is moderatebuy with an average price target of $9.00. Rallies surfaces ENTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ENTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.93 |
| Market Cap | $495.19M |
| P/E Ratio | 12.00 |
| EPS | $0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.20 |
| 52-Week Low | $0.91 |
| Volume | 768.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $42.00K |
| Net Income | $-11.44M |
| Gross Margin | 0.00% |
1 analysts cover ENTX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $9.00.